Atrin Pharmaceuticals LLC
Biotechnology company · Doylestown, Pennsylvania, United States
Atrin Pharmaceuticals LLC is a biotechnology company headquartered in Doylestown, Pennsylvania, United States. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $299,998 in total, most recently in 2016. It has reported private securities offerings to the US SEC, most recently $1.5 million sold in a notice filed in 2016.
Atrin Pharmaceuticals at a glance
What does Atrin Pharmaceuticals do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $299,998 in total (2016). NIH funding came from the National Cancer Institute.
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $1.5 million sold (2016).
Frequently asked questions about Atrin Pharmaceuticals
Where is Atrin Pharmaceuticals headquartered?
Atrin Pharmaceuticals LLC is headquartered in Doylestown, Pennsylvania, United States.
What does Atrin Pharmaceuticals do?
Atrin Pharmaceuticals LLC is a biotechnology company.
Similar companies
- ImCare Biotech, Inc.Doylestown, Pennsylvania, United States
- Thrombolex, Inc.Doylestown, Pennsylvania, United States
- Prolifagen, Inc.Doylestown, Pennsylvania, United States
- IVIEW Therapeutics IncDoylestown, Pennsylvania, United States
- ImmunoGenesis, Inc.Doylestown, Pennsylvania, United States
- Fox Chase Chemical Diversity Center Inc.Doylestown, Pennsylvania, United States
- Conifer Point Pharmaceuticals LLCDoylestown, Pennsylvania, United States
- Chemia Biosciences, Inc.Doylestown, Pennsylvania, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences